drugset / Trial / NCT00295269

Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome

NCT00295269

Phase 3 Completed 200 enrolled National Heart, Lung, and Blood Institute (NHLBI)
RandomizedFactorialDouble-blindTreatment

Summary

The purpose of this study is to assess innovative treatment methods in patients with adult respiratory distress syndrome (ARDS) as well as those at risk of developing ARDS.

Timeline

Start
1997-03
Primary completion
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified